Form 4: Regeneron VP Controller Sells Shares

Regeneron Pharmaceuticals' VP Controller, Jason Pitofsky, sold 431 shares of common stock at $651.43 per share.

Summary

• Jason Pitofsky, the VP Controller of Regeneron Pharmaceuticals, Inc. (REGN), reported a transaction involving the company's common stock.
• On November 7, 2025, Pitofsky disposed of 431 shares of Regeneron Common Stock.
• The shares were sold at a price of $651.43 per share.
• Following this transaction, Pitofsky directly beneficially owns 4,233 shares of Common Stock.
• Additionally, Pitofsky indirectly beneficially owns 31 shares through a 401(k) Plan and 179 shares through a Trust.

Sentiment

Score: 5

Explanation: This is a routine disclosure of an insider stock sale, which is a common event and does not inherently indicate positive or negative company performance or outlook.

Negatives

• Insider selling, even if routine, can sometimes be interpreted by the market as a lack of confidence, though this transaction represents a small percentage of total holdings.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This is a routine disclosure of an individual insider's stock transaction and does not provide broader industry context or competitive analysis.

Stakeholder Impact

• Shareholders: The sale by a VP Controller is a routine disclosure and is unlikely to have a significant direct impact on shareholders, though some may monitor insider activity for sentiment.

Key Dates

Keywords

Regeneron Pharmaceuticals, REGN, Insider Trading, Form 4, Stock Sale, Jason Pitofsky